2010
DOI: 10.1007/s00405-010-1274-3
|View full text |Cite
|
Sign up to set email alerts
|

Salvage surgery for local recurrence after chemoradiotherapy or radiotherapy in hypopharyngeal cancer patients

Abstract: This retrospective study aimed to assess the role of salvage surgery for local recurrence in hypopharyngeal cancer (HPC) patients who had received radiotherapy (RT) or concomitant chemoradiotherapy (CRT) as an initial treatment. The local recurrence rate, salvage rate after local recurrence and overall survival rate were investigated in 104 HPC patients who received treatment between 1991 and 2005. Local recurrence in the primary site was observed in 41 patients (rate, 39.4%) of whom only 12 could undergo furt… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

5
26
0
4

Year Published

2011
2011
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 45 publications
(35 citation statements)
references
References 13 publications
5
26
0
4
Order By: Relevance
“…In this series [5], when the recurrence became unequivocal, most T3 and T4 patients were considered unsuitable to receive surgical salvage. Only two patients of 18 patients (11%) who experienced local recurrence achieved long term survival after surgical salvage.…”
Section: Discussionmentioning
confidence: 98%
See 3 more Smart Citations
“…In this series [5], when the recurrence became unequivocal, most T3 and T4 patients were considered unsuitable to receive surgical salvage. Only two patients of 18 patients (11%) who experienced local recurrence achieved long term survival after surgical salvage.…”
Section: Discussionmentioning
confidence: 98%
“…In their series, Taki et al [5] experienced severe postoperative complications including pharyngocutaneous fistulas in 25% of patients who underwent laryngopharyngectomy. Such complications could severely diminish the quality of life for patients.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Radiation with high-dose cisplatin every 3 weeks remains the most standard regimen in clinical trials by US Cooperative Groups. However, the toxicity of this regimen is too severe for most Japanese patients to complete; therefore, our institute has introduced a regimen of radiation with weekly 40 mg/m 2 of cisplatin [3]. We have to date achieved good clinical outcomes with acceptable toxicity in terms of neutropenia and renal failure [4].…”
Section: Introductionmentioning
confidence: 99%